Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-30

Clinical Trial Update: Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults [Phase 2]

View source ↗

Summary

Phase 2 trial assessing palifermin for increasing CD4 counts in treatment-experienced HIV-infected adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palifermin (palifermin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2012-01-30